WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008095311) USE OF GASEOUS NITRIC OXIDE AS AN ANTI-CANCER AGENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/095311    International Application No.:    PCT/CA2008/000258
Publication Date: 14.08.2008 International Filing Date: 11.02.2008
IPC:
A61K 33/00 (2006.01), A61M 16/06 (2006.01), A61M 16/20 (2006.01), A61P 35/00 (2006.01), A61B 1/012 (2006.01)
Applicants: PULMONOX TECHNOLOGIES CORPORATION [CA/CA]; #107, 10835 - 120 Street, Edmonton, Alberta T5H 3P9 (CA) (For All Designated States Except US).
MILLER, Christopher, C. [CA/CA]; (CA) (For US Only)
Inventors: MILLER, Christopher, C.; (CA)
Agent: SMART & BIGGAR; P.O.Box 2999, Station D, 55 Metcalfe Street, Suite 900, Ottawa, Ontario, K1P 5Y6 (CA)
Priority Data:
11/704,791 09.02.2007 US
Title (EN) USE OF GASEOUS NITRIC OXIDE AS AN ANTI-CANCER AGENT
(FR) UTILISATION DE L'ACIDE NITRIQUE GAZEUX COMME AGENT ANTI-CANCÉREUX
Abstract: front page image
(EN)The invention relates to a method for treating, controlling, or preventing cancerous cell phenotypes and growths in an animal involving the administration of gaseous nitric oxide to one or administration sites in a body. The invention generally is capable of treating cancers found in or on the adrenal gland, bladder, bones, brain, breast, cervix, colon, colorectum, esophagus, gastrointestinal tract, heart, kidney, liver, large intestine, lungs, mouth, ovaries, pancreas, parathyroid, pituitary gland, prostate, salivary gland, skin, small intestine, spleen, stomach, thymus, thyroid, testicles, urinary tract, uterus, vagina, and so forth.
(FR)L'invention porte sur une méthode de traitement, suivi ou prévention, de phénotypes de cellules cancéreuses et de leur croissance chez l'animal, consistant à administrer de d'oxyde nitrique gazeux à un ou des sites d'administration d'un organisme. L'invention est d'une manière générale capable de traiter des formations cancéreuses se trouvant dans ou sur: les glandes surrénales, la vessie, les os, le cerveau, les seins, le col de l'utérus, le côlon, le colorectum, l'oesophage, le tractus gastro-intestinal, le coeur, les reins, le foie, le gros intestin, les poumons, la bouche, les ovaires, le pancréas, la parathyroïde, l'hypophyse, la prostate, les glandes salivaires, la peau, l'intestin grêle, la rate, l'estomac, le thymus, la thyroïde, les testicules, les voies urinaires, l'utérus, le vagin, etc.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)